Cytokinetics Inc (CYTK)
51.48
-0.34
(-0.66%)
USD |
NASDAQ |
Nov 04, 16:00
51.50
+0.02
(+0.04%)
After-Hours: 20:00
Cytokinetics Market Cap: 6.057B for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 6.057B |
| November 01, 2024 | 6.097B |
| October 31, 2024 | 6.001B |
| October 30, 2024 | 6.037B |
| October 29, 2024 | 6.061B |
| October 28, 2024 | 6.149B |
| October 25, 2024 | 6.038B |
| October 24, 2024 | 6.165B |
| October 23, 2024 | 6.241B |
| October 22, 2024 | 6.464B |
| October 21, 2024 | 6.331B |
| October 18, 2024 | 6.468B |
| October 17, 2024 | 6.416B |
| October 16, 2024 | 6.504B |
| October 15, 2024 | 6.516B |
| October 14, 2024 | 6.412B |
| October 11, 2024 | 6.457B |
| October 10, 2024 | 6.254B |
| October 09, 2024 | 6.401B |
| October 08, 2024 | 6.392B |
| October 07, 2024 | 6.527B |
| October 04, 2024 | 6.669B |
| October 03, 2024 | 6.555B |
| October 02, 2024 | 6.190B |
| October 01, 2024 | 6.189B |
| Date | Value |
|---|---|
| September 30, 2024 | 6.212B |
| September 27, 2024 | 6.158B |
| September 26, 2024 | 6.192B |
| September 25, 2024 | 6.198B |
| September 24, 2024 | 6.196B |
| September 23, 2024 | 6.129B |
| September 20, 2024 | 6.327B |
| September 19, 2024 | 6.542B |
| September 18, 2024 | 6.582B |
| September 17, 2024 | 6.608B |
| September 16, 2024 | 6.677B |
| September 13, 2024 | 6.575B |
| September 12, 2024 | 6.361B |
| September 11, 2024 | 6.327B |
| September 10, 2024 | 6.371B |
| September 09, 2024 | 6.569B |
| September 06, 2024 | 6.364B |
| September 05, 2024 | 6.581B |
| September 04, 2024 | 6.458B |
| September 03, 2024 | 6.420B |
| August 30, 2024 | 6.716B |
| August 29, 2024 | 6.752B |
| August 28, 2024 | 6.534B |
| August 27, 2024 | 6.571B |
| August 26, 2024 | 6.715B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
470.33M
Minimum
Nov 12 2019
10.98B
Maximum
Jan 08 2024
3.322B
Average
3.188B
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals Inc | 34.82B |
| Biomarin Pharmaceutical Inc | 12.58B |
| Catalyst Pharmaceuticals Inc | 2.580B |
| Sarepta Therapeutics Inc | 11.74B |
| Ocugen Inc | 273.72M |
Market Cap Related Metrics
| PS Ratio | 1668.64 |
| Price to Book Value | 55.80 |
| Price | 51.48 |
| Earnings Yield | -10.43% |